학술논문
Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old.
Document Type
Article
Author
Source
Human Vaccines & Immunotherapeutics; 2019, Vol. 15 Issue 1, p34-44, 11p
Subject
Language
ISSN
21645515